The multimodal treatment strategies for this tumor are based on a specific risk stratification system that not only considers the TNM system, but also histology, fusion status (PAX3 or 7/FOXO1), anatomical site (favorable vs. unfavorable), size, and age [48, 49]. Here, PAX3 is linked to neoplasm.